H.I.G. Capital, LLC, a leading global private equity firm, today announced that an affiliate has closed its previously announced acquisition of Allion Healthcare, Inc. (NASDAQ: ALLI).
Based in Melville, New York, Allion Healthcare is a leading national provider of specialty pharmacy and disease management services focused on HIV/AIDS patients as well as specialized biopharmaceutical medications and services to chronically ill patients. With over $400 million in revenue, Allion provides critical pharmaceuticals and services to its customers through its network of 17 locations across the country.
Pursuant to the definitive merger agreement between affiliates of H.I.G. Capital and Allion Healthcare, signed on October 18, 2009, stockholders are entitled to receive $6.60 per share in cash. The going-private transaction was approved at the stockholders meeting held on January 11, 2010. The transaction values Allion at approximately $278 million.
Kirkland & Ellis LLP and McDermott Will & Emery LLP (providing regulatory advice) served as legal counsel to H.I.G. and Alston & Bird LLP served as legal counsel to Allion. Raymond James & Associates, Inc. served as financial advisor to the Allion Board of Directors.
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare